Company intelligence / Profile preview

Indago

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Indago is a venture-backed life sciences company developing a breakthrough platform for highly multiplexed, single-molecule protein analysis. Based in Cambridge, Massachusetts, the company aims to transform proteomics by providing a high-sensitivity, scalable solution for detecting and quantifying proteins across the entire proteome. Its technology is designed to support drug discovery and development by enabling researchers to identify novel biomarkers and understand complex biological pathways at the single-molecule level. The company is currently in the pre-clinical stage, focusing on the development and validation of its core technology platform to provide unprecedented sensitivity and scale for protein detection.

Therapeutic areas: Other
Modalities: PlatformProteinDevice
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Indago.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indago.

Explore the full profile